Stephen S Rich1. 1. Center for Public Health Genomics and Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
Abstract
PURPOSE OF REVIEW: The genetic basis of type 1 diabetes (T1D) is being characterized through DNA sequence variation and cell type specificity. This review discusses the current understanding of the genes and variants implicated in risk of T1D and how genetic information can be used in prediction, intervention and components of clinical care. RECENT FINDINGS: Fine mapping and functional studies has provided resolution of the heritable basis of T1D risk, incorporating novel insights on the dominant role of human leukocyte antigen (HLA) genes as well as the lesser impact of non-HLA genes. Evaluation of T1D-associated single nucleotide polymorphisms (SNPs), there is enrichment of genetic effects restricted to specific immune cell types (CD4 and CD8 T cells, CD19 B cells and CD34 stem cells), suggesting pathways to improved prediction. In addition, T1D-associated SNPs have been used to generate genetic risk scores (GRS) as a tool to distinguish T1D from type 2 diabetes (T2D) and to provide prediagnostic data to target those for autoimmunity screening (e.g. islet autoantibodies) as a prelude for continuous monitoring and entry into intervention trials. SUMMARY: Genetic susceptibility accounts for nearly one-half of the risk for T1D. Although the T1D-associated SNPs in white populations account for nearly 90% of the genetic risk, with high sensitivity and specificity, the low prevalence of T1D makes the T1D GRS of limited utility. However, identifying those with highest genetic risk may permit early and targeted immune monitoring to diagnose T1D months prior to clinical onset.
PURPOSE OF REVIEW: The genetic basis of type 1 diabetes (T1D) is being characterized through DNA sequence variation and cell type specificity. This review discusses the current understanding of the genes and variants implicated in risk of T1D and how genetic information can be used in prediction, intervention and components of clinical care. RECENT FINDINGS: Fine mapping and functional studies has provided resolution of the heritable basis of T1D risk, incorporating novel insights on the dominant role of human leukocyte antigen (HLA) genes as well as the lesser impact of non-HLA genes. Evaluation of T1D-associated single nucleotide polymorphisms (SNPs), there is enrichment of genetic effects restricted to specific immune cell types (CD4 and CD8 T cells, CD19 B cells and CD34 stem cells), suggesting pathways to improved prediction. In addition, T1D-associated SNPs have been used to generate genetic risk scores (GRS) as a tool to distinguish T1D from type 2 diabetes (T2D) and to provide prediagnostic data to target those for autoimmunity screening (e.g. islet autoantibodies) as a prelude for continuous monitoring and entry into intervention trials. SUMMARY: Genetic susceptibility accounts for nearly one-half of the risk for T1D. Although the T1D-associated SNPs in white populations account for nearly 90% of the genetic risk, with high sensitivity and specificity, the low prevalence of T1D makes the T1D GRS of limited utility. However, identifying those with highest genetic risk may permit early and targeted immune monitoring to diagnose T1D months prior to clinical onset.
Authors: Jeffrey P Krischer; Kristian F Lynch; Desmond A Schatz; Jorma Ilonen; Åke Lernmark; William A Hagopian; Marian J Rewers; Jin-Xiong She; Olli G Simell; Jorma Toppari; Anette-G Ziegler; Beena Akolkar; Ezio Bonifacio Journal: Diabetologia Date: 2015-02-10 Impact factor: 10.122
Authors: Andrea K Steck; Fran Dong; Randall Wong; Alexandra Fouts; Edwin Liu; Jihane Romanos; Cisca Wijmenga; Jill M Norris; Marian J Rewers Journal: Pediatr Diabetes Date: 2013-11-08 Impact factor: 4.866
Authors: Anette G Ziegler; Marian Rewers; Olli Simell; Tuula Simell; Johanna Lempainen; Andrea Steck; Christiane Winkler; Jorma Ilonen; Riitta Veijola; Mikael Knip; Ezio Bonifacio; George S Eisenbarth Journal: JAMA Date: 2013-06-19 Impact factor: 56.272
Authors: Tobias L Lenz; Aaron J Deutsch; Buhm Han; Xinli Hu; Yukinori Okada; Stephen Eyre; Michael Knapp; Alexandra Zhernakova; Tom W J Huizinga; Gonçalo Abecasis; Jessica Becker; Guy E Boeckxstaens; Wei-Min Chen; Andre Franke; Dafna D Gladman; Ines Gockel; Javier Gutierrez-Achury; Javier Martin; Rajan P Nair; Markus M Nöthen; Suna Onengut-Gumuscu; Proton Rahman; Solbritt Rantapää-Dahlqvist; Philip E Stuart; Lam C Tsoi; David A van Heel; Jane Worthington; Mira M Wouters; Lars Klareskog; James T Elder; Peter K Gregersen; Johannes Schumacher; Stephen S Rich; Cisca Wijmenga; Shamil R Sunyaev; Paul I W de Bakker; Soumya Raychaudhuri Journal: Nat Genet Date: 2015-08-10 Impact factor: 38.330
Authors: L Nisticò; R Buzzetti; L E Pritchard; B Van der Auwera; C Giovannini; E Bosi; M T Larrad; M S Rios; C C Chow; C S Cockram; K Jacobs; C Mijovic; S C Bain; A H Barnett; C L Vandewalle; F Schuit; F K Gorus; R Tosi; P Pozzilli; J A Todd Journal: Hum Mol Genet Date: 1996-07 Impact factor: 6.150
Authors: Wendy K Chung; Karel Erion; Jose C Florez; Andrew T Hattersley; Marie-France Hivert; Christine G Lee; Mark I McCarthy; John J Nolan; Jill M Norris; Ewan R Pearson; Louis Philipson; Allison T McElvaine; William T Cefalu; Stephen S Rich; Paul W Franks Journal: Diabetologia Date: 2020-09 Impact factor: 10.122